3 Indian Growth Stocks To Own In October 2026

US inflation recently rose to 3.7% as energy costs climbed, reminding investors how quickly rising prices can erode cash sitting on the sidelines. Indian growth stocks with significant insider ownership offer a different angle. Management teams with material skin in the game often stay focused on long term value creation during choppy conditions. This article highlights three such fast growing Indian stocks that fit that profile.

The three stocks highlighted here offer a compelling starting point if you want exposure to fast growing businesses where insiders are heavily invested alongside you. However, if you want the names that matter most, these 40 high growth high conviction stocks are the strongest companies we've found.

Rubicon Research (NSEI:RUBICON)

Overview: Rubicon Research is a specialty pharmaceutical business that develops proprietary RubiReten and RubiSRL based treatments in high growth therapeutic areas.

Operations: Rubicon Research generates about ₹19.4b in revenue from pharmaceutical products, including generics, specialty formulations, APIs and related services.

Market Cap: ₹252.2b

Rubicon Research lines up neatly with this screener because its proprietary drug delivery platforms sit at the center of a push into higher margin, faster growing treatment categories that management and analysts both view positively.

"Consistent R&D investment at roughly 10% to 11% of revenue, together with a track record of commercialising 88% of approved products, points to a deeper product basket that can support future revenue and earnings visibility."

What ultimately matters for investors is how a single shift in that product mix filters through to pricing power, profitability and future growth.

When that mix shift starts to bite, the full narrative for Rubicon Research explains how pricing power, capital allocation and insider alignment could be accelerating or masking the true potential here.

Privi Speciality Chemicals (BSE:530117)

Overview: Privi Speciality Chemicals manufactures and exports specialty aroma and fragrance ingredients used in personal care, home-care and fine fragrance products, tying its growth closely to consumer demand.

Operations: Privi Speciality Chemicals generates about ₹26.7b in revenue from speciality oleo chemicals, led by high value aroma and fragrance ingredients.

Market Cap: ₹132.3b

Privi Speciality Chemicals fits this screener because its aroma chemicals portfolio links directly into global demand for scented everyday products, with both management and analysts signalling confidence in the current growth phase.

"Ongoing capacity expansion from roughly 48,000 tonnes to 54,000 tonnes, combined with continuous process intensification and debottlenecking, increases operating leverage as fixed costs are spread over higher output."

What really matters for Privi Speciality Chemicals is how a single shift in product mix and customer adoption shapes its pricing power.

That pricing power question is exactly what the full narrative for Privi Speciality Chemicals unpacks, revealing how capacity, contracts and capital choices could be accelerating or masking the next phase for Privi Speciality Chemicals.

Bajel Projects (NSEI:BAJEL)

Overview: Bajel Projects delivers EPC solutions for high voltage power transmission and distribution, supplying poles, substations and underground cabling for rapid grid buildout.

Operations: Bajel Projects generates about ₹27.5b in revenue from power transmission and power distribution EPC contracts and related infrastructure services.

Market Cap: ₹18.1b

Bajel Projects is aligned with the screener theme, with 71% earnings growth, large high voltage EPC orders and optimistic forecasts that exceed broader Indian expectations. Investors gain exposure to grid expansion and high insider alignment, while one less visible pressure could determine how much of that project pipeline converts into durable margins and cash flow.

That margin pressure is exactly where the analysis report for Bajel Projects starts to show whether Bajel Projects’ order book is quietly compounding value or stretching the balance sheet.

Seeking Alternatives Before The Crowd?

Fresh momentum often starts quietly, then moves fast once the crowd catches on. Scan these curated ideas while the data is still under the radar for now and consider positioning before it becomes widely followed.

• Target reliable cash generators by filtering for a curated list of solid balance sheet and fundamentals (203 results) that can keep funding growth without relying heavily on fresh capital.
• Explore early income opportunities by reviewing 217 dividend fortresses that aim to maintain attractive yields while many investors are still focused elsewhere.
• Consider structural demand for critical materials by checking 32 best rare earth metal stocks before momentum traders concentrate in a narrow set of tickers.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com